Literature DB >> 30653672

British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018.

J Berth-Jones1, L S Exton2, E Ladoyanni3, M F Mohd Mustapa2, V M Tebbs4, P D Yesudian5, N J Levell6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30653672     DOI： 10.1111/bjd.17587

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

Review 1.  A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine.

Authors:  Sonia Pandey; Purnima Tripathi; Arti Gupta; Jitendra Singh Yadav
Journal:  Drug Deliv Transl Res       Date:  2021-09-22       Impact factor: 4.617

Review 2.  Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review.

Authors:  Joanna Nowaczyk; Karolina Makowska; Adriana Rakowska; Mariusz Sikora; Lidia Rudnicka
Journal:  Dermatol Ther (Heidelb)       Date:  2020-04-08

3.  Biologics for severe, chronic plaque psoriasis: An Australian cost-utility analysis.

Authors:  Helen Y Sun; Elena Keller; Harish Suresh; Deshan F Sebaratnam
Journal:  JAAD Int       Date:  2021-08-09

Review 4.  Global Guidelines in Dermatology Mapping Project (GUIDEMAP), a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased, trustworthy and evidence based (CUTE)?

Authors:  Bernd W M Arents; Esther J van Zuuren; Sofieke Vermeulen; Jan W Schoones; Zbys Fedorowicz
Journal:  Br J Dermatol       Date:  2022-05       Impact factor: 11.113

5.  Breastfeeding by a mother taking cyclosporine for nephrotic syndrome.

Authors:  Ruizhe Li; Chuan Zhang; Hongjing Wang; Yunfei An
Journal:  Int Breastfeed J       Date:  2022-10-17       Impact factor: 3.790

Review 6.  Psoriasis and Treatment: Past, Present and Future Aspects.

Authors:  Claire Reid; Christopher E M Griffiths
Journal:  Acta Derm Venereol       Date:  2020-01-30       Impact factor: 3.875

Review 7.  COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement.

Authors:  Charlie Wang; Marius Rademaker; Christopher Baker; Peter Foley
Journal:  Australas J Dermatol       Date:  2020-05-03       Impact factor: 2.481

Review 8.  COVID-19 Outbreak: Pathogenesis, Current Therapies, and Potentials for Future Management.

Authors:  Md Farhad Hossain; Sharifa Hasana; Abdullah Al Mamun; Md Sahab Uddin; Mir Imam Ibne Wahed; Sabarni Sarker; Tapan Behl; Irfan Ullah; Yesmin Begum; Israt Jahan Bulbul; Md Shah Amran; Md Habibur Rahman; May N Bin-Jumah; Saad Alkahtani; Shaker A Mousa; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Front Pharmacol       Date:  2020-10-16       Impact factor: 5.810
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.